ANXA5 and breast neoplasm: It was observed that treatment with PDA NPs•Tmab@PTX increased the number of early apoptotic HER2+ breast tumor cells (7AAD−/Annexin V+) in a similar manner than treatment with an equivalent concentration of free PTX (Figure 4b).